At Phico, we are developing a unique antibiotic technology to address one the most urgent challenges facing medicine today – how to destroy multi-drug resistant bacteria, the so-called “superbugs”. Our patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. With a number of advantages over conventional antibiotic classes, SASPject™ could form the basis for a new generation of antibiotics to overcome antimicrobial resistance. Watch our animation to discover how our technology works: https://www.youtube.com/channel/UCjPndK0F9ufmEy9fBQFTsUg Twitter: @Phicotx Youtube: Phico Therapeutics Ltd
View Top Employees from Phico Therapeutics Ltd.Website | http://www.phicotx.co.uk |
Revenue | $4 million |
Employees | 16 (16 on RocketReach) |
Founded | 2000 |
Phone | +44 1954 741040 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Medical, Pharmaceutical, Therapeutics |
Competitors | Antitope Ltd, An Abzena Company, Celldex Therapeutics, Isogenica Limited, Millipore Corporation |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies |
Looking for a particular Phico Therapeutics Ltd. employee's phone or email?
The Phico Therapeutics Ltd. annual revenue was $4 million in 2024.
Aled Charles is the CMC Director of Phico Therapeutics Ltd..
16 people are employed at Phico Therapeutics Ltd..
The NAICS codes for Phico Therapeutics Ltd. are [5417, 541, 54171, 54, 541714].
The SIC codes for Phico Therapeutics Ltd. are [87, 873].